Related Experiment Video
Updated: Jun 23, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Effects of Serum Potassium on Mortality in Patients With ST-Elevation Myocardial Infarction
Colton J Jensen1, Jonathan K Nielsen1, Matthew M Talbott1
1Department of Emergency Medicine, University of Texas Medical Branch at Galveston, Galveston, USA.
Insights
Potassium levels impact ST-elevation myocardial infarction (STEMI) outcomes. Both low (hypokalemia) and high (hyperkalemia) potassium significantly increase mortality and ventricular arrhythmias in STEMI patients.
Area of Science:
- Cardiology
- Clinical Research
- Biomedical Science
Background:
- Potassium disturbances are known to trigger ventricular arrhythmias and increase mortality in ST-elevation myocardial infarction (STEMI) patients.
- Existing clinical guidelines may not fully address the risks associated with varying serum potassium (sK) levels in STEMI.
Purpose of the Study:
- To investigate the association between serum potassium (sK) levels and seven-day mortality in STEMI patients.
- To determine the impact of sK levels on the incidence of ventricular arrhythmias (ventricular tachycardia and ventricular fibrillation) in STEMI.
Main Methods:
- A retrospective analysis of approximately 250,000 STEMI patients from the TriNetX database.
- Patients were categorized into four sK cohorts: hypokalemia (≤3.4 mEq/L), normal (3.5–4.5 mEq/L), high-normal (4.6–5.0 mEq/L), and hyperkalemia (≥5.1 mEq/L).
- Propensity-matched analysis was used to compare seven-day mortality, ventricular tachycardia (VT), and ventricular fibrillation (VF) rates across cohorts.
Main Results:
- Hypokalemia was associated with a 69% increased risk of seven-day mortality (RR 1.69) and higher VT/VF rates compared to normal sK.
- Hyperkalemia showed a 176% increased risk of mortality (RR 2.76) and elevated VT/VF rates.
- High-normal sK levels were linked to a 58% increased mortality risk (RR 1.58) without a significant change in VT/VF rates.
Conclusions:
- Serum potassium levels, including hypokalemia, hyperkalemia, and high-normal ranges, are significantly correlated with increased mortality in STEMI patients.
- Both hypokalemia and hyperkalemia substantially elevate the risk of life-threatening ventricular arrhythmias (VT/VF).
- The findings underscore the importance of monitoring and managing potassium levels in STEMI management to improve patient outcomes.
Introduction:
Disturbances in potassium levels can induce ventricular arrhythmias and heighten mortality in patients with ST-elevation myocardial infarction (STEMI). This study evaluates the influence of sK levels on seven-day mortality and incidence of ventricular arrhythmias in STEMI patients to further improve clinical guidelines and outcomes.
Methods:
This retrospective, propensity-matched study analyzed approximately 250,000 acute STEMI patients from 55 major academic medical centers/healthcare organizations (HCOs) in the US Collaborative Network of the TriNetX database. The sK levels recorded on the day of STEMI diagnosis were categorized into four cohorts: sK ≤ 3.4 (hypokalemia), 3.5 ≤ sK ≤ 4.5 (normal-control), 4.6 ≤ sK ≤ 5.0 (high-normal), and sK ≥ 5.1 (hyperkalemia). Patient cohorts were propensity-matched using linear and logistic regression for demographics. Outcomes of seven-day mortality, ventricular tachycardia (VT), and ventricular fibrillation (VF) were compared between these cohorts and the control group.
Results:
The analysis showed hypokalemia was linked to significantly higher seven-day mortality (7.2% vs. 4.3%; RR 1.69; p<0.001), and increased rates of VT and VF. Similarly, hyperkalemia was associated with elevated mortality (12.7% vs. 4.6%; RR 2.76; p<0.001), VT, and VF rates. High-normal sK levels showed increased mortality (7.4% vs. 4.7%; RR 1.58; p<0.001), but unchanged VT or VF rates compared to the normal sK group.
Conclusion:
This comprehensive study highlights the correlation of sK levels with death in STEMI patients, revealing a nearly doubled risk of mortality with hypokalemia and almost triples with hyperkalemia. More notably, the mortality for STEMIs is higher for high-normal vs normal sK values. Additionally, hypokalemia and hyperkalemia were found to significantly elevate VT and VF risks.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Diuretics
Roles of Electrolytes: Sodium and Potassium